Q & A
Contact Us
Beijing BoardingCard:
TEL:+86-10-87671126
FAX: +86-10-8767 6595
E-MAIL:  lenaliu@bjboardingcard.com   
 peterwangpeng@bjboardingcard.com
ADD: Ryan Building Room 1123, East 3rd. Ring South Rd. No. 102, Chaoyang District, Beijing, 100021, China
About data requirements 您的位置 > 首页 > Q & A > About data requirements
Question
When applying for regular registration for highly hazardous substances, do applicants have to submit social and economic benefit analysis materials for new chemical substance activities?

Answer
Yes. It is necessary to submit an explanation including whether the new chemical substance has comparable or obvious advantages in terms of performance and environmental friendliness compared with the chemical substance in use for the same purpose, so as to fully demonstrate the necessity of the application activity.

Question
Q: The existing reports and data of a substance demonstrate that it is a PBT substance. Is it possible to conduct simple registration based on the activity volume?

Answer
No. It is recommended that more data be used for a more accurate assessment of the substance.
Question
Based on what data to determine the toxicity of substances?

Answer
The aquatic toxicity, carcinogenicity, mutagenicity, reproductive toxicity, chronic toxicity and specific target organ toxicity of the substance will affect the determination of the toxicity of the substance. Please consult us for specific determination criteria.

Question
Based on what data to determine bioaccumulation?

Answer
The log kow value of a substance can be used to screen the bioaccumulation of a substance, and the BCF value is the criterion for the bioaccumulation of a substance. Please consult Boardingcard for the specific determination process.
Question
Based on what data to determine the persistence?

Answer
Persistence determination is a complex and highly professional work. According to determination standards and screening criteria, the screening evaluation process is used for determination. The basic data requirements in the "Guideline" can only be used to determine the screening criteria, and cannot be directly determined based on the criteria. When evaluating a substance, we need to use the weight of evidence method to determine based on the structure, properties, existing data, QSAR, and cross-reference of the substance. For details, please consult Boardingcard.